BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28146434)

  • 1. Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes.
    Dickman CT; Lawson J; Jabalee J; MacLellan SA; LePard NE; Bennewith KL; Garnis C
    Oncotarget; 2017 Feb; 8(9):15252-15266. PubMed ID: 28146434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p.
    Yang X; Wu X
    Oncol Rep; 2016 Jan; 35(1):398-408. PubMed ID: 26498065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.
    Liu C; Zhou X; Long Q; Zeng H; Sun Q; Chen Y; Wu D; Liu L
    Oncogene; 2021 Jan; 40(2):233-245. PubMed ID: 33110233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
    BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
    Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
    Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
    Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
    Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
    J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells.
    Kim O; Hwangbo C; Tran PT; Lee JH
    Cell Death Dis; 2022 Feb; 13(2):122. PubMed ID: 35136055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma.
    Liu Z; Diep C; Mao T; Huang L; Merrill R; Zhang Z; Peng Y
    Oncol Rep; 2015 Dec; 34(6):2961-8. PubMed ID: 26503628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
    He J; Ye W; Kou N; Chen K; Cui B; Zhang X; Hu S; Liu T; Kang L; Li X
    J Cell Mol Med; 2020 Jan; 24(1):841-849. PubMed ID: 31680452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
    Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
    J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-140-5p regulates adipocyte differentiation by targeting transforming growth factor-β signaling.
    Zhang X; Chang A; Li Y; Gao Y; Wang H; Ma Z; Li X; Wang B
    Sci Rep; 2015 Dec; 5():18118. PubMed ID: 26657345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNAs that target amyloid precursor protein processing machinery in extracellular vesicles and particles derived from oral squamous cells carcinoma.
    Galvão F; Rode MP; de Campos PS; Bruch GE; Carregal VM; Massensini AR; Matte BF; Lamers ML; Creczynski-Pasa TB; Siqueira IR
    J Oral Pathol Med; 2023 Oct; 52(9):877-884. PubMed ID: 37549991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.